George R. Painter
Chief Executive Officer at Drug Innovation Ventures At Emory LLC
Profile
George R.
Painter was the founder of Chimerix, Inc. (founded in 2000) where he held the position of Director & Chief Scientific Officer from 2011 to 2012.
Dr. Painter is also the founder of Altesa BioSciences, Inc., Drug Innovation Ventures At Emory LLC.
Currently, Dr. Painter is the President & Chief Executive Officer at Emory Institute For Drug Development and a Director at Koronis Pharmaceuticals, Inc. Dr. Painter's former positions include Director-Research Process at Glaxo Wellcome, Inc., Director-Chemistry & Virology at Burroughs Wellcome, and Executive Vice President-Research & Development at Triangle Pharmaceuticals, Inc. Dr. Painter received his undergraduate, graduate, and doctorate degrees from Emory University.
George R. Painter active positions
| Companies | Position | Start |
|---|---|---|
Koronis Pharmaceuticals, Inc.
 Koronis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Koronis Pharmaceuticals, Inc. develops antiviral therapeutics based on viral decay acceleration. Its therapeutics are designed to inhibit a specific viral protein or enzyme, drugs based on VDA are designed to provoke the rapid decay of the targeted virus by further increasing its naturally high rate of mutation. The company was founded by Richard Daifuku in 1998 and is headquartered in Seattle, WA. | Director/Board Member | - |
Emory Institute For Drug Development
 Emory Institute For Drug Development Miscellaneous Commercial ServicesCommercial Services Emory Institute For Drug Development engages in drug discovery and development in industry and academia. It provides organization, facilities and resources to translate academic drug discovery into clinical candidates. The company was founded by Dennis C. Liotta in 2009 and is headquartered in Atlanta, GA. | Chief Executive Officer | - |
| Drug Innovation Ventures At Emory LLC | Chief Executive Officer | - |
Former positions of George R. Painter
| Companies | Position | End |
|---|---|---|
| CHIMERIX, INC. | Founder | 2012-07-19 |
Altesa Biosciences, Inc.
 Altesa Biosciences, Inc. BiotechnologyHealth Technology Altesa BioSciences, Inc. develops oral recombinant vaccines. The company is based in College Park, GA. The company was founded by Dennis C. Liotta, George R. Painter, Seth A. Rudnick, John M. Clerici, Samuel Candler Dobbs. The CEO is Brett P. Giroir. | Founder | - |
| Burroughs Wellcome | Corporate Officer/Principal | - |
| Glaxo Wellcome, Inc. | Corporate Officer/Principal | - |
Triangle Pharmaceuticals, Inc.
 Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC. | Chief Tech/Sci/R&D Officer | - |
Training of George R. Painter
| Emory University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CHIMERIX, INC. | Health Technology |
| Private companies | 7 |
|---|---|
Triangle Pharmaceuticals, Inc.
Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC. | Commercial Services |
Koronis Pharmaceuticals, Inc.
Koronis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Koronis Pharmaceuticals, Inc. develops antiviral therapeutics based on viral decay acceleration. Its therapeutics are designed to inhibit a specific viral protein or enzyme, drugs based on VDA are designed to provoke the rapid decay of the targeted virus by further increasing its naturally high rate of mutation. The company was founded by Richard Daifuku in 1998 and is headquartered in Seattle, WA. | Health Technology |
| Glaxo Wellcome, Inc. | Health Technology |
| Burroughs Wellcome | |
Emory Institute For Drug Development
Emory Institute For Drug Development Miscellaneous Commercial ServicesCommercial Services Emory Institute For Drug Development engages in drug discovery and development in industry and academia. It provides organization, facilities and resources to translate academic drug discovery into clinical candidates. The company was founded by Dennis C. Liotta in 2009 and is headquartered in Atlanta, GA. | Commercial Services |
Altesa Biosciences, Inc.
Altesa Biosciences, Inc. BiotechnologyHealth Technology Altesa BioSciences, Inc. develops oral recombinant vaccines. The company is based in College Park, GA. The company was founded by Dennis C. Liotta, George R. Painter, Seth A. Rudnick, John M. Clerici, Samuel Candler Dobbs. The CEO is Brett P. Giroir. | Health Technology |
| Drug Innovation Ventures At Emory LLC |
- Stock Market
- Insiders
- George R. Painter
